Analyst Profile

Followed by 158 followers
.
Suraj Kalia

Suraj Kalia

Oppenheimer
Wall Street Analyst
#1,110 out of 8,112 Wall Street Analysts
#2,335 out of 24,193 experts

Success Rate

52%
216 out of 415 transactions made a profit

Average Return

+5.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Suraj Kalia's trades since 2010 and holding each position for 1 Year would result in 52.05% of your transactions generating a profit, with an average return of 5.4% per rating.

Stock Rating Distribution

751Ratings
51.93% Buy
36.88% Hold
11.19% Sell
Distribution of Suraj Kalia's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Viewray Inc.
(VRAY)
Rating:Buy
Date:Mar 12, 2020 - Mar 12, 2021
Return:+240.70%
The most profitable rating made by Suraj Kalia

Suraj Kalia's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
SurModics
Sep 20, 2010
Hold
Upgraded
$10.00
(-72.24% Downside)
1Ratings
0.00%
Walgreens Boots Alliance
Mar 04, 2013
Sell
Initiated
$400.00
(860.15% Upside)
1Ratings
0%
-69.00%
Abiomed
Nov 06, 2013
Sell
Assigned
$14.00
(-96.30% Downside)
4Ratings
33%
-12.23%
Xtant Medical Holdings
Mar 20, 2014
Buy
Reiterated
$20.00
(2822.27% Upside)
2Ratings
0%
-38.40%
Alimera
Sep 29, 2014
Buy
Reiterated
$10.00
(160.78% Upside)
3Ratings
33%
-12.30%
EDAP TMS
Sep 29, 2014
Hold
Downgraded
4Ratings
0.00%
Adynxx
Feb 24, 2015
Buy
Reiterated
$8.00
(7999900.00% Upside)
2Ratings
0%
-72.30%
~THOR
Thoratec Corp
Jul 22, 2015
Buy
Reiterated
7Ratings
40%
+16.08%
MiMedx Group
Oct 30, 2015
Buy
Upgraded
$10.00
(220.51% Upside)
9Ratings
80%
+31.04%
HTWR
HeartWare International
Feb 26, 2016
Hold
Reiterated
9Ratings
100%
+17.22%
List of latest recommendations made by Suraj Kalia. Click to expand and see Suraj Kalia's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >